In fact, FAK inhibition has been found to suppress tumor cell migration and invasion in a variety of human malignancies, such as gastric, lung, oral and ovarian cancer, as well as in melanoma, hepatoblastoma and neuroblastoma [52–60]. Here, PTK2 is linked to neuroblastoma.